Minocycline Extended-Release Tablets and Recombinate recombinant
Determining the interaction of Minocycline Extended-Release Tablets and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: minocycline
Brand name: Dynacin, Minocin, Minocin PAC, Minolira, Solodyn, Ximino, Vectrin, Myrac
Synonyms: Minocycline, Minocycline (Systemic)
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Minocycline Extended-Release Tablets-Recombivax
- Minocycline Extended-Release Tablets-Recombivax HB
- Minocycline Extended-Release Tablets-Recombivax HB Adult
- Minocycline Extended-Release Tablets-Recombivax HB Dialysis Formulation
- Minocycline Extended-Release Tablets-Recombivax HB Pediatric/Adolescent
- Minocycline Extended-Release Tablets-Recort Plus
- Recombinate recombinant-Minocycline Hydrochloride
- Recombinate recombinant-Minocycline Hydrochloride eent
- Recombinate recombinant-Minocycline Hydrochloride Periodontal Microspheres
- Recombinate recombinant-Minocycline Injection
- Recombinate recombinant-Minocycline Intravenous
- Recombinate recombinant-Minocycline mucous membrane powder